Sox-2 is key to promoting gastric cancer cell proliferation and chemoresistance [39], thus exploring its regulatory network may uncover mechanisms driving tumor aggressiveness, recurrence, and therapy resistance, offering new targets for treatment. Here, SOX2 is linked to neoplasm.